Traynor Capital Management, Inc. Pfizer Inc Call Options Transaction History

Traynor Capital Management, Inc.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2024 Oct 24, 2024	SELL	$27.7 - $31.39 $263,150 - $298,205	-9,500 Reduced 12.1%	69,000 $2 Million
Q2 2024 Jul 24, 2024	BUY	$25.26 - $29.6 $1.98 Million - $2.32 Million	78,500 New	78,500 $2.2 Million

3,258

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Traynor Capital Management, Inc. with notifications on news.